Key Insights

Highlights

Success Rate

88% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 27/100

Termination Rate

5.6%

1 terminated out of 18 trials

Success Rate

87.5%

+1.0% vs benchmark

Late-Stage Pipeline

11%

2 trials in Phase 3/4

Results Transparency

57%

4 of 7 completed with results

Key Signals

4 with results88% success

Data Visualizations

Phase Distribution

15Total
Not Applicable (5)
P 1 (6)
P 2 (2)
P 4 (2)

Trial Status

Completed7
Active Not Recruiting5
Recruiting2
Withdrawn2
Not Yet Recruiting1
Terminated1

Trial Success Rate

87.5%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (18)

Showing 18 of 18 trials
NCT03036930Phase 2Active Not Recruiting

Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients

NCT04927650Active Not Recruiting

Prevention and Early Detection of Cervical Cancer Through Self-Administered Screening

NCT02379520Phase 1CompletedPrimary

HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA

NCT03634267Phase 1Active Not RecruitingPrimary

MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal Cancer

NCT05232851Phase 1Active Not Recruiting

A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer

NCT02568566Phase 2Active Not RecruitingPrimary

Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger Healthy Participants

NCT05985681Phase 1RecruitingPrimary

Testing RG1-VLP Vaccine to Prevent HPV-related Cancers

NCT06926062Not ApplicableNot Yet RecruitingPrimary

Interpersonal Communication Training and Vaccination Workflow Training Alone and in Combination to Improve Communication and Recommendations About HPV Vaccination in Pharmacies, IMPACT HPV Trial

NCT04474821Phase 4Completed

HPV Educational Intervention to Increase Acceptance and Completion of Free HPV Vaccination Among Underserved Adults

NCT04580446Phase 1CompletedPrimary

HYHOPE: De-intensified Hypofractionated Radiation Therapy for HPV-associated Oropharynx Cancer

NCT07104240Not ApplicableRecruitingPrimary

A Vaccine Promotion Package (TweenVax) to Improve Adolescent HPV Vaccination, TweenVax Trial

NCT04142398Withdrawn

Incidence of HPV Infection and HPV-Associated Disease in Screening Indian Men Who Have Sex With HIV-Positive Men

NCT05831540Not ApplicableTerminatedPrimary

Clinical Decision Support Tools to Increase Human Papillomavirus (HPV) Vaccination in Adolescents in Pharmacies

NCT04880837Not ApplicableCompletedPrimary

Human Papillomavirus Education Programs

NCT05472220Phase 1Withdrawn

Alpelisib in Combination With Carboplatin in Patients With Solid Tumors and HPV-Positive Squamous Cell Carcinoma

NCT04189003Completed

Molecular Signatures of HPV+ ORL Cancers (OROPAP)

NCT02624349Phase 4Completed

Immunogenicity and Safety of Human Papilloma Virus Vaccine in Solid Organ Transplant Recipients

NCT01769560Not ApplicableCompletedPrimary

MeFirst: A Tailored Intervention to HPV Vaccine Decision Making

Showing all 18 trials

Research Network

Activity Timeline